期刊文献+

石蜡包埋B细胞淋巴瘤组织克隆性IgH基因重排的检测 被引量:4

Determination of clonal immunoglobulin heavy chain gene rearrangement in paraffin-embedded tissues from B-cell lymphomas
下载PDF
导出
摘要 目的 探讨克隆性免疫球蛋白重链第三互补决定簇区 (IgHCDR3)基因重排在B细胞非霍奇金淋巴瘤 (B NHL)诊断方面的价值。方法 采用半巢式PCR、聚丙烯酰胺凝胶电泳 (PAGE)及银染技术 ,检测 38例B NHL、4例T NHL及 10例慢性扁桃腺炎 ,经福尔马林固定、石蜡包埋病理组织的克隆性IgHCDR3重排。结果  2 9例B NHL及1例免疫组化未能明确细胞来源的NHL克隆性IgHCDR3重排阳性 ;4例T NHL及 10例慢性扁桃腺炎克隆性IgHC DR3重排阴性。结论 克隆性IgHCDR3重排可作为B NHL与反应性增生鉴别的特异性标志 。 Objective To evaluate the significance of clonal gene rearrangement of the third complementarity determining region of immunoglobulin heavy chain (IgHCDR3) in the diagnosis of B cell non Hodgkin's lymphoma (B NHL). Methods Semi nested polymerase chain reaction, polyacrylamide gel electrophoresis and silver staining were used to detect clonal IgHCDR3 gene rearrangement in formalin fixed and paraffin embedded tissues from 38 cases of B NHL, 4 T NHL and 10 chronic tonsillitis. Results Clonal IgHCDR3 rearrangements were detected in 78.4% of B NHL (29/37) and one case of NHL that the lineage of tumor cells was unknown by immunohistochemical staining. Negative results were seen in 4 cases of T NHL and 10 chronic tonsillitis. Conclusion Clonal IgHCDR3 gene rearrangement can be used as a specific molecular marker for differential diagnosis of B cell tumors from reactive lymphoproliferative diseases and as a B cell lineage marker in most cases.
出处 《诊断病理学杂志》 CSCD 2001年第5期280-281,共2页 Chinese Journal of Diagnostic Pathology
关键词 淋巴瘤 B细胞 免疫球蛋白重链 基因重排 克隆性 聚合酶链反应 Lymphoma, B cell Immunoglobulin heavy chain gene rearrangement Clonality Polymerase chain reaction
  • 相关文献

参考文献6

二级参考文献8

共引文献26

同被引文献24

  • 1赵广法,蔡三军,师英强,陈中伟.胰腺实性-假乳头状瘤1例[J].实用全科医学,2005,3(3):226-226. 被引量:3
  • 2石岚,李惠民.实时定量PCR检测IgH重排在B淋巴细胞恶性肿瘤中的应用[J].白血病.淋巴瘤,2005,14(3):189-191. 被引量:2
  • 3Jaffy ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and lymphoid tissues [M]. Lyon: IARC Press, 2001,111 -235.
  • 4Chuang SS, Lin CN, Li CY. Malignant lymphoma in Southern Taiwan according to the revised European-American classification of lymphoid neoplasma[J]. Cancer,2000,89(7): 1586 - 1592.
  • 5Ko YH, Kim CW, Park CS, et al. REAL Classification of Malignant Lymphoma in the Repubic of Korea[J]. Cancer, 1998,83 (4): 806 -812.
  • 6Izumo T, Uehara T, Kis K, et al. Malignant lymphoma inJapanese HTLV1-noendemic area based on the REAL classification [J]. Ann Oncol, 1996,7(Suppl 3): A342.
  • 7SiebertJD, Mulvaney DA, Potter KL, et al. Relative frequencies and sites of presentation of lymphoid neoplasms in a community hospital according to the revised European-American classification[J]. AmJClin Pathol, 1999,111(3) :379 - 386.
  • 8AndersonJR, ArmitageJO, Weisenburger DD. Epidemiology of the non-Hodgkin' s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin' s Lymphoma Classification Project[J]. Ann Oncol, 1998,9(7) :717 - 720.
  • 9Ball TB,Plummer FA,HayGlass KT. Improved Mrna quantitation in LightCycler RT-PCR[J].International Archives of Allergy and Applied Immunology,2003,(01):82.doi:10.1159/000068372.
  • 10Galimeberti S,Marasca R,Caracciolo F. The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma[J].Bone Marrow Transplantation,2002,(07):581-587.doi:10.1038/sj.bmt.1703422.

引证文献4

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部